“Evaluation of Inflammatory and Biochemical Markers in COVID-19 Patients Treated With Tocilizumab Alone or With the Combination of Tocilizumab and Convalescent Plasma Transfusion”. 2022. Annals of Medical Research 29 (7): 770-76. http://annalsmedres.org/index.php/aomr/article/view/4231.